Logo for Editas Medicine Inc

Editas Medicine Investor Relations Material

Latest events

Logo for Editas Medicine Inc

AGM 2024

Editas Medicine
Logo for Editas Medicine

AGM 2024

30 May, 2024
Logo for Editas Medicine

Q1 2024

8 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Editas Medicine Inc

Access all reports
Segment Data
Access more data
Revenue by
Source
Collaboration and other research and development revenues
Expenses by
Financials
Editas Medicine, a genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company seeks to address the fundamental flaws in existing approaches to genetic and infectious diseases by developing TALEN and CRISPR genome editing systems that function more efficiently than existing technologies. It has invented lymphocyte-directed gene therapy that uses CRISPR/Cas9 technology to manufacture a novel endonuclease. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.